• CBR Announces A New Course – Observational Research Protocols: An Introduction

    7 April 2021
    The Center for Bioethics and Research has announced yet another new course “Observational Research Protocols: An Introduction” in partnership with Collaborative Institutional Training Initiative (CITI). Observational studies are important and exceedingly useful in the biomedical and social sciences, as well as other fields such as education. This concise course covers the essentials of observational research protocol design and development. (more…)
    Continue Reading
  • NSCR, FMOH unveils Cancer in Nigeria, Volume II (2009 – 2016)

    15 March 2021

    The Nigerian National System of Cancer Registries (NSCR) in conjunction with the Federal Ministry of Health (FMOH) has unveiled the second edition of the reference text Cancer in Nigeria, which data from 2009 to 2016. (more…)

    Continue Reading
  • Presentation of H3Africa ACCME Genome-Wide Analysis Study results at NCI

    8 March 2021

    Dr. Clement Adebamowo will  be presenting on “Genome-Wide Analysis Study of Persistent high-risk HPV infection: Results from an H3Africa Collaborative Center”.

    Date: June 8, 2021
    Time: 3-4pm ET

    Register for the webinar here  >  https://bit.ly/3qompqP


    Continue Reading
  • Prof. Adebamowo teams up with other researchers on COVID-19 Vaccine Hesitancy Study

    3 February 2021

    Clement A. Adebamowo, BM, ChB, ScD, FWACS, FACS, professor of epidemiology and public health at the Institute of Human Virology at University of Maryland School of Medicine, and Xiaoli Nan, PhD, MA, a professor of communication science and co-director of Graduate Studies in the Department of Communication at University of Maryland, College Park.

    When faculty members from the University of Maryland, Baltimore (UMB) and the University of Maryland, College Park (UMCP) wanted to assemble an interdisciplinary team of researchers to find out what influences the African American community when it comes to vaccine hesitancy, there was no trepidation in wondering if the colleagues would receive support.

    Many of us on both campuses who have interacted see us as belonging to one institution,” said Clement A. Adebamowo, BM, ChB, ScD, FWACS, FACS, professor of epidemiology and public health at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) and associate director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center’s (UMGCCC) Population Science Program. (more…)

    Continue Reading
  • 2021 Multilevel Intervention Training Institute (MLTI) Applications Now Being Accepted – Due 12/31/20

    23 December 2020

    Application Period Open Through December 31, 2020

    The National Cancer Institute (NCI) is pleased to announce a training program to provide participants with critical skills in designing, conducting, evaluating, and reporting multilevel intervention research within cancer care delivery.

    The Multilevel Intervention Training Institute (MLTI) is intended to build capacity and skills for researchers in the field of cancer care to further multilevel intervention research (e.g., delivering seminars, forming new collaborations, mentoring, and submitting grant proposals responsive to NCI funding announcements).  (more…)

    Continue Reading
  • Microbiome Joint eSymposia Scholarships & Abstract Opportunities

    4 December 2020

    The first set of Microbiome Joint eSymposia Scholarships & Abstract Opportunities is coming up and Scholarship and Abstract opportunities are already coming up for applications.

    Click the banner graphics below for more information.

    This image has an empty alt attribute; its file name is e-symp-opportunities4-1030x343.png
    Continue Reading
  • 2021 Annual Global Symposium on Global Cancer Research – Call for Abstracts

    30 October 2020

    The 9th Annual Symposium on Global Cancer Research will be held virtually March 10-11, 2021, as a satellite meeting to the 12th Annual Consortium of Universities for Global Health (CUGH) Global Health Conference.

    The Symposium is organized through a collaboration with the US National Cancer Institute Center for Global Health, CUGH, Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Texas MD Anderson Cancer Center, the American Society of Clinical Oncology (ASCO), and the American Association for Cancer Research (AACR).

    Call for Abstracts

    The organizers invite all persons wishing to report original research, projects, or programs related to global cancer research and control to submit abstracts.

    Evaluation Criteria

    • Public health significance: addresses relevant public health question
    • Methodology: methods chosen are appropriate for research, project, or program
    • Overall impact: enhances understanding of global cancer burden/aims to improve global cancer control
    • Clarity of ideas

    Abstracts must include the following sections with the headlines:

    • Purpose
    • Methods
    • Results
    • Conclusion


    • All abstracts must be submitted in English.
    • Abstract maximum word count is 300.
    • Abstract titles must be 250 characters or less and should not be submitted in all caps.
    • Abstracts should not contain figures or tables.
    • Only one abstract per person as presenting or first author may be submitted. (Note: There is a maximum of three abstracts total per author).
    • Authors will be asked to select a topic area(s) relevant to their abstract at the time of submission.

    The six topic areas have been identified from the International Cancer Research Partnership’s (ICRP) Common Scientific Outline (CSO) classification system. For definitions and more information on CSO codes, please visit https://www.icrpartnership.org/cso. The six topic areas include:
    – Biology
    – Etiology
    – Prevention
    – Early detection, diagnosis, and prognosis
    – Treatment o Cancer control, survivorship, and outcomes research

    Abstracts must be submitted online by December 16, 2020 at 11:59pm EST.

    Only abstracts that comply with all the above guidelines will be considered for presentation and publication. Authors will receive decisions and more information about the virtual platform and presentations via email January 2021. Accepted abstracts will be selected for poster and/or oral presentation and will be published later in 2021 in an AACR journal.

    For event information, please visit the Symposium Website

    For all questions regarding abstracts, please contact Linsey Eldridge: linsey.eldridge@nih.gov

    Continue Reading
  • Apply for 2021 Clinical Investigator Award (CIA) and Young Investigator Award (YIA)

    30 October 2020

    DEADLINE: Tuesday, JANUARY 12, 2021

    The SSO is accepting proposals for the 2021-2023 Clinical Investigator Award (CIA) and the 2021 Young Investigator Award (YIA) through Tuesday, January 12, 2021. The purpose of these awards is to promote patient-oriented research conducted by surgical oncologists in clinical and translational science. Interested researchers are invited to apply for the award. Applications are reviewed and selected by members of the SSO Research Committee.

    CIA Basic Eligibility and Terms

    • Applicants for the CIA must be surgical oncologists within 8 years of completion of training

    The award will be funded for two years at $100,000 ($50,000 per year) and is given to the sponsoring institution. Funding will begin on April 1, 2021. Learn more and access complete application details.

    Apply for the Clinical Investigator Award


    YIA Basic Eligibility and Terms

    • Applicants for the YIA must be surgical oncologists within 5 years of completion of training
    • The award will be funded for one year at $25,000 and is given to the sponsoring institution. Funding will begin on April 1, 2021. Learn more and access complete application details.
    Apply for the Young Investigator Award


    For both awards, applicants must be an SSO member for at least six months prior to application. Award recipients will be announced at the SSO 2021, Virtual Meeting, March 18-20. Applicants will be informed of the outcome via email shortly after the conclusion of the meeting.

    Remember, submit your CIA application or YIA application on or before January 12, 2021 for consideration. Please contact Jeanette Ruby via email with any questions.

    Continue Reading
  • 13th Science of D&I Conference: Scholarships Available for Individuals from Low- and Middle-Income Countries

    20 October 2020
    AcademyHealth is seeking participation from individuals of low- and middle-income countries at this year’s virtual Science of D&I Conference. Scholarships have been made available to cover the registration fee for individuals who would benefit for participating.
    Applicants for the scholarship must come from low- and middle-income countries and who would be otherwise unable to participate in the absence of registration support.
    The Scholarship Includes:

    1. One complimentary registration to the 13th Annual Science of D&I Conference.
    2. Access to all recorded live and on-demand presentations.

    Friday, November 6, 2020

    Register here

    If you know individuals who would benefit from this scholarship, please pass along the information.
    Continue Reading
  • More Keystone Symposia Financial Aid to attend eSymposia

    14 October 2020

    Keystone Symposia is offering a limited number of free registrations to early career scientists, as well as participants from low- and middle- income countries (LMICs), to attend the new eSymposia series. This new digital format enables the inclusion of more diverse voices and global perspectives in conversations at the forefront of science and medicine, which are essential to shape research that serves the broad needs of all of humanity. (more…)

    Continue Reading